publication . Doctoral thesis . 2011

New Insights into Medical Treatment of Acromegaly

Neggers, Bas;
Open Access English
  • Published: 10 Jun 2011
  • Publisher: Erasmus University Rotterdam
  • Country: Netherlands
Abstract
textabstractGiants and Acromegalics fascinated people, since ancient times. Historical artifacts, paintings, illustrations, photographs or articles have documented many. The earliest medical reports date back to 1516. In 1864 Verga was the first to describe an acromegalic in medical literature and called it “prosopectasia”. However the article did not really characterize the disease. Pierre Marie was the first to do so and describe the disease and gave it the final name “acromegalie”, in 1886. Although Pierre Marie was aware of the enlarged pituitary gland he did not describe this as cause of the disease. In 1887 Minkowski was the first to suggest a pituitary or...
Subjects
free text keywords: acromegaly
Related Organizations
Download from

20. Kreutzer J, Vance ML, Lopes MB, Laws ER, Jr. (2001) Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria. The Journal of clinical endocrinology and metabolism 86 (9):4072-4077 [OpenAIRE]

21. Barker FG, 2nd, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the United States, 1996-2000: mortality, morbidity, and the eefcts of hospital and surgeon volume. The Journal of clinical endocrinology and metabolism 88 (10):4709-4719 [OpenAIRE]

22. Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB (1998) Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. The Journal of clinical endocrinology and metabolism 83 (10):3411-3418 [OpenAIRE]

23. Bates PR, Carson MN, Trainer PJ, Wass JA, Group UKNARS (2008) Wide variation in surgical outcomes for acromegaly in the UK. Clinical endocrinology 68 (1):136-142

24. Melmed S (2006) Medical progress: Acromegaly. The New England journal of medicine 355 (24): 2558-2573 [OpenAIRE]

25. Minniti G, Jafrain-Rea ML, Osti M, Esposito V, Santoro A, Solda F, Gargiulo P, Tamburrano G, Enrici RM (2005) The long-term eficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clinical endocrinology 62 (2):210-216

26. Jenkins PJ, Bates P, Carson MN, Stewart PM, Wass JA (2006) Conventional pituitary irradiation is eefctive in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. The Journal of clinical endocrinology and metabolism 91 (4):1239-1245

27. Biermasz NR, van Dulken H, Roelfsema F (2000) Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly. The Journal of clinical endocrinology and metabolism 85 (7):2476-2482

28. Petrossians P, Borges-Martins L, Espinoza C, Daly A, Betea D, Valdes-Socin H, Stevenaert A, Chanson P, Beckers A (2005) Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs. European journal of endocrinology / European Federation of Endocrine Societies 152 (1):61-66

29. Bevan JS (2005) Clinical review: The antitumoral eefcts of somatostatin analog therapy in acro - megaly. The Journal of clinical endocrinology and metabolism 90 (3):1856-1863

30. Carlsen SM, Lund-Johansen M, Schreiner T, Aanderud S, Johannesen O, Svartberg J, Cooper JG, Hald JK, Fougner SL, Bollerslev J (2008) Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. The Journal of clinical endocrinology and metabolism 93 (8):2984- 2990

31. van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, HermanBonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO (2001) Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet 358 (9295):1754-1759 [OpenAIRE]

32. Drake WM, Parkinson C, Besser GM, Trainer PJ (2001) Clinical use of a growth hormone receptor antagonist in the treatment of acromegaly. Trends in endocrinology and metabolism: TEM 12 (9): 408-413 [OpenAIRE]

33. Orme SM, McNally RJ, Cartwright RA, Belchetz PE (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. The Journal of clinical endocrinology and metabolism 83 (8):2730-2734

34. Bates AS, Van't Hof W, Jones JM, Clayton RN (1993) An audit of outcome of treatment in acro - megaly. The Quarterly journal of medicine 86 (5):293-299

Powered by OpenAIRE Research Graph
Any information missing or wrong?Report an Issue